To change the medical community's standard of care for many conditions as quickly as possible! There are many conditions previously not recognized before Mark's research and subsequent patent filing relating to the use of Alpha1 Antitrypsin, Alpha1 Antitrypsin Deficiency, and the new comorbidities discovered by Mark Egly relating to Alpha1 Antitrypsin!
To revitalize and restart the agricultural and pharmaceutical industry's interest in developing medical-grade Alpha1 Antitrypsin again! Mark's discoveries show that a greater demand for the Alpha1 Antitrypsin protein exists today!
To educate every medical facility, medical educational institution, and medical professional that there is much more to know about Alpha1 Antitrypsin Deficiency and the use of Alpha1 Antitrypsin in non-deficient patients is essential for all in the medical arena to understand!
To educate the public on Alpha1 Antitrypsin!
Start saving more lives immediately through all these initiatives!
To turn this personal project of Mark's over to the medical professionals of the world to see how high they can soar with these medical discoveries!